Leonid Poretsky

Last updated
Leonid Poretsky
Poretsky Leonid 1956.jpg
BornAugust 7, 1954
Leningrad, USSR
Education St. Petersburg Medical University
Beth Israel Hospital, Boston
Harvard Medical School
Occupation(s) Physician, endocrinologist
Years active1977–present
Employer Northwell Health
OrganizationGerald J. Friedman Diabetes Institute of Lenox Hill Hospital

Leonid Poretsky (born August 7, 1954) is a Russian-born American endocrinologist. His research interests include mechanisms of insulin action in the ovary, [1] endocrinological aspects of AIDS, [2] and clinical outcomes in diabetes. [3] [4] [5] He has authored over 150 publications and has served on the National Institutes of Health's review committees and on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and other endocrine journals. [6]

Contents

As of 2014 he is a professor of medicine at Hofstra Northwell School of Medicine in Hempstead, New York, and Chief of the Division of Endocrinology at Lenox Hill Hospital in Manhattan, New York.

Early life, career

Leonid Poretsky was born on August 7, 1954, in Leningrad, Russian SSR. [6] His mother, Nina, was a well known pediatrician from Bobruisk, Belarus who lived and worked in Leningrad. [7] His father was a prominent engineer. [8] Poretsky graduated from First (Pavlov) Medical Institute in Leningrad (now St. Petersburg State Medical University), cum laude in 1977. [6]

He immigrated with his family to the United States in 1979. Upon completing his internal medicine residency program, he began a fellowship in endocrinology and metabolism at Boston’s Beth Israel Hospital (now Beth Israel/Deaconess Medical Center). He also completed a research fellowship in medicine at Harvard Medical School (1983–1985), where he was mentored by Dr. Jeffrey Flier. [6]

Beth Israel Medical Center

While at Beth Israel Medical Center (2000 - 2014), Dr. Poretsky served as Chief of the Division of Endocrinology, Vice-Chairman for Research, and Interim Chairman in the Department of Medicine. He held the Gerald J. Friedman endowed chair in endocrinology and metabolism at Beth Israel Medical Center and was a founding director of the Gerald J. Friedman Diabetes Institute. [6]

Gerald J. Friedman Diabetes Institute is an education, clinical management and research program focused on diabetes which requires no insurance or physician referral. At the institute Poretsky chairs the annual Friedman Fellows Symposia, which present the work of fellows from around the US supported by The Gerald J. and Dorothy R. Friedman New York Foundation for Medical Research. [9]

Lenox Hill Hospital

In September 2014, Dr. Poretsky joined the staff of Lenox Hill Hospital as its Chief of the Division of Endocrinology. He is leading the effort to develop academic and clinical programs. An endocrinology fellowship program was initiated in July 2016 and a new site for the Gerald J. and Dorothy R. Friedman Diabetes Institute at Lenox Hill Hospital opened on August 1, 2016. Another specialized program in the division—Friedman Transgender Health and Wellness Program—opened in 2017. The division has numerous grants from philanthropic organizations, industry and government agencies (New York State Department of Health and the National Institutes of Health). Lenox Hill Hospital is a part of Northwell Health, formerly North Shore – LIJ Health System, a network of hospitals, nursing homes, a medical school, a nursing school, a medical research institute, ambulatory care centers, urgent care centers, a health insurance company, and laboratories.

Dr. Poretsky has regularly appeared in the New York Times Magazine Best Doctors List and the U.S. News & World Report Best Doctors List. [6]

Publishing

Medical texts

Poretsky has authored over 150 publications, and has served on the editorial board of the Journal of Clinical Endocrinology and Metabolism , [6] Journal of Diabetes, and other publications. [6]

He contributed to and edited the comprehensive textbook Principles of Diabetes Mellitus, which has been widely cited, [10] and has gone through three editions so far (2002, 2010 and 2017 [10] [11] [12] ). The book covers a wide range of topics on diabetes. [10] [11] [12]

In 2012 he edited Diabetes Mellitus: A Concise Clinical Guide, which covers "the basics of diagnosis, complications, therapies and prevention of diabetes." The book consists of sections originally published in the second edition of Principles of Diabetes Mellitus. [13]

He is also a series editor for “Contemporary Endocrinology”. (Springer, Inc.)

A comprehensive textbook "Transgender Medicine - Multidisciplinary Approach" co-edited by Leonid Poretsky, MD and Wylie Hembree, MD was published in 2019 (Springer Publishers, Inc.) [14]

In 2023 he co-edited with Dr. Dimitar Avtanski a monograph "Obesity, Diabetes and Inflammation".

Public policy

Poretsky has been vocal in the media about how health care policy can affect patient care. In the 1990s he wrote a letter to the editor of New York Times concerning how Medicaid payment caps can limit physicians' availability to patients. [15] In July 2012 he wrote an op-ed for Forbes which drew comparisons between the bureaucratic behavior of the American healthcare system and that of the Soviet Union's, which he says "collapsed under the weight of its own bureaucratic inefficiencies two decades ago." [16] This article was followed in 2013 by a publication on the subject entitled “The sovietization of American medicine: Notes from the front lines”, which appeared in the Journal of American Physicians and Surgeons . [17]

In 2013 he published a letter in the Wall Street Journal talking about inadequate methods used by the government to assess hospital performance [18] and a letter regarding policy changes needed to reduce hospital readmissions. [19] In 2017, he published a letter about Medicare being allowed to compete with private health insurance plans. [20] In 2021 he was interviewed by USA today regarding transgender health care. [21] In 2022 he co-authored a letter in the New York Times regarding medical care of transgender youth. [22]

In 2023 he published an editorial in POZ magazine regarding government influence in transgender care. [23]

Notable research

Insulin in the human ovary

While working as a research fellow at Harvard in the early 1980s, Poretsky became known for discovering, describing and characterizing insulin receptors in the human ovary. [24]

Before his research, the hormone insulin had been known to primarily regulate glucose and other fuel metabolism in the liver, fat, and muscle. [24] His work established the ovary as a target for regulation by insulin, and introduced a new paradigm for the gonadotropic function of insulin. [25]

Poretsky had been researching the causes of hyperandrogenism (high level of male hormones and male features in females) in patients with extreme forms of insulin resistance, for example in people with insulin receptor gene mutations. [24] Subsequently, Poretsky’s work became important for understanding more common disorders, such as polycystic ovary syndrome (PCOS), which affects up to 10% of reproductive age women and is associated with infertility and diabetes. [26] Poretsky’s work helped lead to the use of insulin-sensitizing agents in patients with PCOS. [27] [28]

Poretsky and his coworkers also characterized related receptors in the ovary (insulin-like growth factor receptors, [29] peroxisome-proliferator activated receptor-gamma), [30] [31] embarked on early studies of the newly discovered energy metabolism hormone irisin in reproduction, [32] and conceptualized an insulin-related ovarian regulatory system. [1]

AIDS/HIV

Another line of Poretsky's research involved endocrine manifestations of acquired immunodeficiency syndrome (AIDS), and includes an early review of endocrinological dysfunction in AIDS patients. [33]

Additionally, in 1987 Poretsky was a key member of the team which described a condition called hyporeninemic hypoaldosteronism, which is characterized by deficiency of adrenal hormone aldosterone, in patients with AIDS. This discovery resulted in introduction of treatment with fludrocortisone, which proved to be extremely effective and almost immediately converted most patients with this condition from being unable to stand (because of a severe drop in blood pressure upon standing) to being mobile and more functional. [2]

Poretsky was also key in an early description of a type of inflammation of the thyroid (thyroiditis) which is caused by an opportunistic infection of the thyroid gland by an organism which had been known to infect only the lungs of patients with AIDS. [34] However, Drucker et al published a case of thyroiditis due to pneumocystis infection the year before Poretsky. [35]

He also studied the metabolism of adrenal hormones cortisol [36] and dehydroepiandrosterone (DHEA) [37] [38] in patients with human immunodeficiency virus (HIV).

Clinical studies in diabetes

Poretsky’s other publications address a variety of subjects in diabetes and reproduction. Recent publications include an invited editorial in the Proceedings of the National Academy of Sciences on the role of advanced glycation end products (AGEs) in metabolic disease; [39] [40] a study of the potential new treatment for prevention of diabetic nephropathy (carried out in collaboration with investigators from the Mount Sinai School of Medicine); [41] a review of the role of Vitamin D in human reproduction; [42] and an editorial as well as a clinical research study [43] on the problem of recurrent hospitalizations of patients with diabetes. [44] In 2021 he has published on applications of modern glucose monitoring technology in hospitalized patients with diabetes during COVID 19 epidemic. [45]

Related Research Articles

<span class="mw-page-title-main">Polycystic ovary syndrome</span> Set of symptoms caused by abnormal hormones in females

Polycystic ovary syndrome, or polycystic ovarian syndrome (PCOS), is the most common endocrine disorder in women of reproductive age. The syndrome is named after cysts which form on the ovaries of some people with this condition, though this is not a universal symptom, and not the underlying cause of the disorder.

Insulin resistance (IR) is a pathological condition in which cells either fail to respond normally to the hormone insulin or downregulate insulin receptors in response to hyperinsulinemia.

<span class="mw-page-title-main">Hirsutism</span> Excessive hair growth on parts of the body where hair is usually minimal

Hirsutism is excessive body hair on parts of the body where hair is normally absent or minimal. The word is from early 17th century: from Latin hirsutus meaning "hairy". It usually refers to a male pattern of hair growth in a female that may be a sign of a more serious medical condition, especially if it develops well after puberty. Cultural stigma against hirsutism can cause much psychological distress and social difficulty. Discrimination based on facial hirsutism often leads to the avoidance of social situations and to symptoms of anxiety and depression.

<span class="mw-page-title-main">Type 2 diabetes</span> Type of diabetes mellitus with high blood sugar and insulin resistance

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Symptoms may also include increased hunger, having a sensation of pins and needles, and sores (wounds) that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Resistin</span> Mammalian protein found in Homo sapiens

Resistin also known as adipose tissue-specific secretory factor (ADSF) or C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein (XCP1) is a cysteine-rich peptide hormone derived from adipose tissue that in humans is encoded by the RETN gene.

<span class="mw-page-title-main">Hyperandrogenism</span> Medical condition

Hyperandrogenism is a medical condition characterized by high levels of androgens. It is more common in women than men. Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation. Complications may include high blood cholesterol and diabetes. It occurs in approximately 5% of women of reproductive age.

<span class="mw-page-title-main">Primary hyperparathyroidism</span> Medical condition

Primary hyperparathyroidism is a medical condition where the parathyroid gland produce excess amounts of parathyroid hormone (PTH). The symptoms of the condition relate to the resulting elevated serum calcium (hypercalcemia), which can cause digestive symptoms, kidney stones, psychiatric abnormalities, and bone disease.

<span class="mw-page-title-main">Carney complex</span> Medical condition

Carney complex and its subsets LAMB syndrome and NAME syndrome are autosomal dominant conditions comprising myxomas of the heart and skin, hyperpigmentation of the skin (lentiginosis), and endocrine overactivity. It is distinct from Carney's triad. Approximately 7% of all cardiac myxomas are associated with Carney complex.

<span class="mw-page-title-main">Endocrine disease</span> Medical condition

Endocrine diseases are disorders of the endocrine system. The branch of medicine associated with endocrine disorders is known as endocrinology.

<span class="mw-page-title-main">Steroid 11β-hydroxylase</span> Protein found in mammals

Steroid 11β-hydroxylase, also known as steroid 11β-monooxygenase, is a steroid hydroxylase found in the zona glomerulosa and zona fasciculata of the adrenal cortex. Named officially the cytochrome P450 11B1, mitochondrial, it is a protein that in humans is encoded by the CYP11B1 gene. The enzyme is involved in the biosynthesis of adrenal corticosteroids by catalyzing the addition of hydroxyl groups during oxidation reactions.

<span class="mw-page-title-main">CAPN10</span> Protein-coding gene in the species Homo sapiens

Calpain-10 is a protein that in humans is encoded by the CAPN10 gene.

<span class="mw-page-title-main">Aromatase deficiency</span> Medical condition

Aromatase deficiency is a rare condition characterized by extremely low levels or complete absence of the enzyme aromatase activity in the body. It is an autosomal recessive disease resulting from various mutations of gene CYP19 (P450arom) which can lead to ambiguous genitalia and delayed puberty in females, continued linear growth into adulthood and osteoporosis in males and virilization in pregnant mothers. As of 2020, fewer than 15 cases have been identified in genetically male individuals and at least 30 cases in genetically female individuals.

Derek LeRoith is a South African endocrinologist and Professor of Medicine and the current Chief of the Hilda and J. Lester Gabrilove, M.D. Division of Endocrinology, Diabetes and Bone Disease and Director of the Metabolism Institute of the Mount Sinai Medical Center in New York City. He is an international expert in insulin-like growth factor-1 (IGF-1).

Cyril Y. Bowers, M.D., emeritus professor of medicine at Tulane University School of Medicine, attended medical school at the University of Oregon and did an internship at the University of Washington. He then studied biochemistry at Cornell University and attended the postgraduate school of medicine at the University of Pennsylvania. From 1961-2004 he was the director of the Section of Endocrinology & Metabolism in the department of medicine at Tulane University School of Medicine. Bowers has served on the editorial board of several endocrine journals, was a member of the National Institute of Diabetes and Digestive and Kidney Diseases Study Section for eight years and has written over 400 articles in peer-reviewed journals, including chapters in books and over 200 abstracts.

Bernhard Ludvik is a Specialist in Internal Medicine, board certified in Endocrinology and Metabolism. He is currently an Associate Professor of Medicine at the Medical University of Vienna. He serves as the Deputy Head of the Division of Endocrinology and Metabolism at the General Hospital Vienna.

Margo Panush Cohen is an American physician and entrepreneur. She has been a Professor of Internal Medicine and Chief of Endocrinology and Metabolism at the Wayne State University School of Medicine and the University of Medicine and Dentistry of New Jersey. She is President and Chief Scientific Officer of Glycadia, and a founder of its subsidiary Exocell.

<span class="mw-page-title-main">HAIR-AN syndrome</span> Medical condition

The HAIR-AN syndrome is a rare subtype of polycystic ovary syndrome (PCOS) characterized by hyperandrogenism (HA), insulin resistance (IR) and acanthosis nigricans (AN). The symptoms of the HAIR-AN syndrome are largely due to severe insulin resistance, which can be secondary to blocking antibodies against the insulin receptor or genetically absent/reduced insulin receptor number/function. Insulin resistance leads to hyperinsulinemia which, in turn, leads to an excess production of androgen hormones by the ovaries. High levels of androgen hormones (hyperandrogenism) in females causes excessive hair growth, acne and irregular menstruation. Patients with both underlying mechanisms of insulin resistance may have more severe hyperandrogenism. Insulin resistance is also associated with diabetes, heart disease and excessive darkening of the skin

Robert A. Vigersky is an American endocrinologist, Professor of Medicine at the Uniformed Services University of the Health Sciences, and pioneering military healthcare professional. His career has focused on diabetes care, research, and advocacy, publishing 148 papers and 118 abstracts in the fields of reproductive endocrinology and diabetes. Vigersky is a retired colonel in the U.S. Army Medical Corps, past president of the Endocrine Society, and recipient of the General Maxwell R. Thurman Award. He served in Iraq, Korea and Germany and is the recipient of military awards including the U.S. Army's Legion of Merit in 2009.

The Thyrotroph Thyroid Hormone Sensitivity Index is a calculated structure parameter of thyroid homeostasis. It was originally developed to deliver a method for fast screening for resistance to thyroid hormone. Today it is also used to get an estimate for the set point of thyroid homeostasis, especially to assess dynamic thyrotropic adaptation of the anterior pituitary gland, including non-thyroidal illnesses.

Robert Hardin Williams was a physician, specializing in endocrinology and diabetology. He was the 49th President of The Endocrine Society.

References

  1. 1 2 Poretsky, L; Cataldo, N; Rosenwaks, Z; Guidice, L (1999). "Insulin-related ovarian regulatory system in health and disease". Endocrine Reviews. 20 (4): 535–582. doi: 10.1210/edrv.20.4.0374 . PMID   10453357.
  2. 1 2 Kalin, MF; Poretsky, L; Seres, DS; Zumoff, B (May 1987). "Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome". Am J Med. 82 (5): 1035–8. doi:10.1016/0002-9343(87)90171-9. PMID   3555065.
  3. ↑ Aronoff, S; Rosenblatt, S; Braithwaite, S; Egan, JW; Mathisen, AL; Schneider, RL (November 2000). "The Pioglitazone 001 Study Group (2000). Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes" (PDF). Diabetes Care. 23 (11): 1605–1611. doi: 10.2337/diacare.23.11.1605 . PMID   11092281.
  4. ↑ Brillon, DJ; Sison, CP; Salbe, AD; Poretsky, L (2006). "Reproducibility of a glycemic response to mixed meals in type 2 diabetes mellitus". Hormone and Metabolic Research. 38 (8): 536–542. doi:10.1055/s-2006-949526. PMID   16941281. S2CID   21422950.
  5. ↑ Pittas, AG; Dawson-Hughes, B; Sheehan, P; Rosen, C; Ware, JH; Knowler, WC; Staten, M (2014). "The D2d Research Group (2014). Rationale and design of the vitamin D and type 2 diabetes (D2d) Study: A diabetes prevention study" (PDF). Diabetes Care. 37 (12): 3227–3234. doi:10.2337/dc14-1005. PMC   4237973 . PMID   25205139.
  6. 1 2 3 4 5 6 7 8 "Leonid Poretsky: CV" (PDF). Friedman Diabetes Institute. January 2017. Retrieved 2017-03-09.
  7. ↑ "Nina Poretsky M.D." The New York Times . March 2, 2004. Retrieved 2013-04-27.
  8. ↑ "Deaths: Ruvim Poretsky". The New York Times . June 18, 2006. Retrieved 2013-03-12.
  9. ↑ "Dr. Leonid Poretsky". Friedman Diabetes Institute. Retrieved 2012-01-12.
  10. 1 2 3 editor, Leonid Poretsky (2010). Principles of diabetes mellitus (2nd ed.). New York: Springer. p. 3. ISBN   978-0-387-09840-1.{{cite book}}: |last= has generic name (help)
  11. 1 2 Poretsky, Leonid (2002). Principles of Diabetes Mellitus. Springer. p. 20. ISBN   1402071140.
  12. 1 2 Poretsky, Leonid (2017). Principles of Diabetes Mellitus. Springer. ISBN   978-3-319-18740-2.
  13. ↑ Poretsky, Leonid (2012). Diabetes Mellitus: A Concise Clinical Guide. Springer. ISBN   9781461457077.
  14. ↑ editor, L. Poretsky & W. Hembree (2019). Transgender medicine-Multidisciplinary Approach (1st ed.). New York: Springer. ISBN   978-3-030-05683-4.{{cite book}}: |last= has generic name (help)
  15. ↑ Poretsky, Leonid (July 3, 1990). "A Medicaid Proposal". New York Times . Retrieved 2013-04-27.
  16. ↑ Poretsky, Leonid (July 3, 2012). "Stop the Sovietization of American Medicine". Forbes . Retrieved 2013-04-27.
  17. ↑ Poretsky, L (2013). "The sovietization of American medicine: Notes from the front lines". Journal of American Physicians and Surgeons. 18 (2): 50–54.
  18. ↑ Poretsky, Leonid (April 19, 2013). "Physician, Hear Thyself—Why Communication Matters". Wall Street Journal . Retrieved 2013-03-12.
  19. ↑ Poretsky, Leonid (May 20, 2013). "Readmissions Often Aren't Culpable Acts". The Wall Street Journal . Retrieved 2013-05-20.
  20. ↑ Poretsky, Leonid (January 19, 2017). "Traditional Medicare should be allowed to compete" (PDF). Education Update . Retrieved 2017-01-19.
  21. ↑ "How doctors' assumptions about LGBTQ patients can be harmful to their health". USA Today . September 30, 2021. Retrieved 2021-09-30.
  22. ↑ Shadianloo, S.; Poretsky, L. (May 1, 2022). "Re: The Rise in Young People Identifying as L.G.B.T.Q." New York Times . Retrieved 2022-05-01.
  23. ↑ Poretsky, L. (August 9, 2023). "A Physician's Duty to Resist Government Interference". POZ . Retrieved 2023-08-09.
  24. 1 2 3 Poretsky, L; Smith, D; Seibel, M; Pazianos, A; Moses, AC; Flier, JS (1984). "Specific insulin binding sites in human ovary". J Clin Endocrinol Metab. 59 (809–811): 809–11. doi: 10.1210/jcem-59-4-809 . PMID   6480806.
  25. ↑ Poretsky, L; Kalin, M (1987). "The gonadotropic function of insulin". Endocrine Reviews. 8 (2): 132–141. doi:10.1210/edrv-8-2-132. PMID   3301317.
  26. ↑ Poretsky, L (2006). "Polycystic ovary syndrome: Increased or preserved ovarian sensitivity to insulin?". J Clin Endocrinol Metab. 91 (8): 2859–2860. doi: 10.1210/jc.2006-0317 . PMID   16684824.
  27. ↑ Bloomgarden, Z; Futterweit, W; Poretsky, L (2001). "Use of insulin sensitizing agents in patients with polycystic ovary syndrome". Endocrine Practice. 7 (4): 279–286. doi:10.4158/EP.7.4.279. PMID   11497481.
  28. ↑ Nandi, A; Chen, Z; Patel, R; Poretsky, L (2014). "Polycystic ovary syndrome". Endocrinology and Metabolism Clinics of North America. 43 (1): 123–147. doi:10.1016/j.ecl.2013.10.003. PMID   24582095. S2CID   20421610.
  29. ↑ Poretsky, L; Grigorescu, F; Moses, AC; Flier, JS (1985). "Distribution and characterization of the insulin and IGF-1 receptors in the human ovary". J Clin Endocrinol Metab. 61 (4): 728–734. doi:10.1210/jcem-61-4-728. PMID   2993346.
  30. ↑ Seto-Young, D; Paliou, M; Schlosser, J; Avtanski, D; Park, A; Patel, P; Holcomb, K; Chang, P; Poretsky, L (2005). "Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production". J Clin Endocrinol Metab. 90 (11): 6099–6105. doi: 10.1210/jc.2005-0469 . PMID   16131582.
  31. ↑ Seto-Young, D; Avtanski, D; Parikh, G; Suwandhi, P; Strizhevsky, M; Araki, T; Rosenwaks, Z; Poretsky, L (2011). "Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interfering with androgen binding to aromatase". Horm Metab Res. 43 (4): 250–256. doi:10.1055/s-0030-1270525. PMID   21321839. S2CID   8792730.
  32. ↑ Poretsky, L; Islam, J; Avtanski, D; Lin, YK; Shen, YL; Hirth, Y; Lesser, M; Rosenwaks, Z; Seto-Young, D (2017). "Reproductive effects of irisin: Initial in vitro studies". Reproductive Biology. 17 (3): 285–288. doi:10.1016/j.repbio.2017.05.011. PMID   28571680.
  33. ↑ Poretsky, L; Maran, A; Zumoff, B (1990). "Endocrinological and metabolic manifestations of AIDS". Mount Sinai Journal of Medicine. 57: 236–241.
  34. ↑ Battan, R; Mariuz, P; Raviglione, MD; Sabatini, MT; Mullen, MP; Poretsky, L (1991). "Pneumocystitis carinii infection of the thyroid in a hypothyroid patient with AIDS: Diagnosis by fine needle aspiration biopsy". J Clin Endocrinol Metab. 72 (3): 724–726. doi: 10.1210/jcem-72-3-724 . PMID   1997526.
  35. ↑ Drucker, D. J.; Bailey, D.; Rotstein, L. (1990). "Thyroiditis as the presenting manifestation of disseminated extrapulmonary Pneumocystis carinii infection". The Journal of Clinical Endocrinology and Metabolism. 71 (6): 1663–1665. doi:10.1210/jcem-71-6-1663. PMID   2229322.
  36. ↑ Stolyarczyk R, Rubio S, Smolyar D, Young I, Poretsky L (June 1998). "24 hr urinary free cortisol in patients with acquired immune deficiency syndrome". Metabolism. 47 (6): 690–4. doi:10.1016/s0026-0495(98)90032-4. PMID   9627368.
  37. ↑ Poretsky, L; Brillon, DJ; Ferrando, S; Chiu, J; McElhiney, M; Ferenczi, A; Sison, CP; Haller, I; Rabkin, J (2006). "Endocrine effects of oral dehydroepiandrosterone (DHEA) in men with HIV infection: A prospective randomized double-blind placebo-controlled trial". Metabolism. 55 (7): 858–870. doi:10.1016/j.metabol.2006.02.013. PMID   16784956.
  38. ↑ Romero, CM; Liao, EP; Zumoff, B; Poretsky, L (2011). "Dehydroepianrosterone (DHEA) in Human Immunodeficiency Virus Infection: Prognostic and Therapeutic Aspects.". In Watson, R (ed.). DHEA in Human Health and Aging. Boca Raton, FL: CRC Press. pp. 195–205..
  39. ↑ Poretsky, L (2012). "Looking beyond overnutrition for causes of epidemic metabolic disease". Proceedings of the National Academy of Sciences of the United States of America. 109 (39): 15537–15538. Bibcode:2012PNAS..10915537P. doi: 10.1073/pnas.1213503109 . PMC   3465375 . PMID   22984158.
  40. ↑ Basman, C; Fishman, SL; Avtanski, D; Rashid, U; Kodra, A; Chen, K; Jonas, R; Stoffels, GJ; Lesser, M; Inlall, D; Ziskovich, K; Singh, VP; Poretsky, L (2020). "Glycosylated hemoglobin, but not advanced glycation end products, predicts severity of coronary artery disease in patients with or without diabetes". Metabolism Open. 7: 100050. doi: 10.1016/j.metop.2020.100050 . PMC   7474000 . PMID   32924001.
  41. ↑ Yubero-Serrano, EM; Woodward, M; Poretsky, L; Vlassara, H; Striker, GE (2015). "Effects of sevelamer carbonate on advanced glycation endproducts and anti-oxidant/pro-oxidant status in patients with diabetes kidney disease". Clinical Journal of the American Society of Nephrology. 10 (5): 59–66. doi:10.2215/CJN.07750814. PMC   4422240 . PMID   25710801.
  42. ↑ Nandi, A; Sinha, N; Ong, W; Sonmez, E; Poretsky, L (2016). "Is there a role for Vitamin D in human reproduction?". Horm Mol Biol Clin Invest. 25 (1): 15–28. doi: 10.1515/hmbci-2015-0051 . PMID   26943610. S2CID   207452819.
  43. ↑ Bhalodkar, A; Sonmez, H; Lesser, M; Leung, T; Ziskovich, K; Inlall, D; Murray-Bachmann, R; Krymskaya, M; Poretsky, L (2020). "The effects of a comprehensive multidisciplinary outpatient diabetes program on hospital readmission rates in patients with diabetes: A randomized controlled prospective study". Endocrine Practice. 26 (11): 1331–1336. doi:10.4158/EP-2020-0261. PMID   33471664. S2CID   225499566.
  44. ↑ Sonmez, H; Kambo, V; Taha, R; Poretsky, L (2016). "Reducing hospital readmissions in patients with diabetes: Developing better strategies". Endocr Pract. 22 (9): 1134–1136. doi:10.4158/EP161315.CO. PMID   27359289.
  45. ↑ Murray-Bachmann, R; Leung, TM; Myers, A; Murthi; Sarbanes, M; Ziskovich, K; Poretsky, L (2021). "Reliability of continuous glucose monitoring system in the inpatient setting". Journal of Clinical & Translational Endocrinology. 25: 100262. doi: 10.1016/j.jcte.2021.100262 . PMC   8318984 . PMID   34336598.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.